Document:

Exhibit

CRITEO 

WARRANT AGREEMENT

[Name], a [nationality] citizen, residing at [address],

hereinafter referred to as the “Beneficiary”,

On [___], 20[___], the board of directors, using the delegation of competence granted to it by the combined ordinary and extraordinary shareholders meeting of CRITEO (the “Company”) held on [___], issued and granted to the benefit of the Beneficiary [_____] warrants (the “Warrants”) under the terms and conditions set forth in this agreement:

Date of Grant:        [___], 20[___]

		
	Subscription Price of the Warrants:
	USD [______] (i.e., USD [____] per Warrant)

Maximum number of ordinary shares to be subscribed 
upon exercise of the Warrants:    [____]
(i.e., 1 per Warrant)

Exercise price per share:    EUR [____]

Term/Expiration date of the Warrant:    [___], 20[___] 

Article 1 - Validity of the Warrants

The Warrants will be validly issued as from the date of their subscription by the Beneficiary subject to the condition precedent that the Beneficiary executes and returns to the Company the subscription form of the Warrants in the form attached as exhibit 1 hereto, duly signed, and makes the following payment on or before [___], 20[___].

The Warrants shall be fully paid up, at subscription, for a total price of USD [_________], in cash or by way of offset against receivables in accordance with applicable French law.

Article 2 - Exercise of the Warrants 

2.1.    Vesting period

The Warrants may be exercised according to the following vesting schedule:

		
	•
	[__] of the Warrants shall vest on [__],

		
	•
	[__] of the Warrants shall vest on [__], and

		
	•
	[__] of the Warrants shall vest on [__];

provided that [(i) in case of termination of the Beneficiary's term of office as board member of the Company, on his own initiative or at the request of the Company, (the “Office Termination”) before the first anniversary of the date of grant, all the Warrants shall be automatically void; and (ii)] any Warrants not exercised on or before [___], 20[___] shall be automatically void.

As an exception to the above, in the event of (i) signature of a merger agreement by way of absorption of the Company by another Company, or in the event of transfer by one or several shareholders of the Company to one or several third parties, acting on their own or jointly, of a number of shares entailing the transfer of the control of the Company (in the meaning of article L. 233-3 of the French commercial code) to this or these third parties (the “Operation”), or (ii) [Office Termination on or after one year 

1

from the date of grant / termination of the Beneficiary’s term of office as board member, either at this own initiative or at the request of the Company (the “Office Termination”)], the exercise rights of the Warrants shall be accelerated in such a way that the Warrants holder can exercise a number of ordinary shares corresponding to 100% of the Warrants not exercisable at the date of completion of said Operation or Office Termination, as applicable.

However, unless otherwise decided by the board of directors in connection with the events below, the exercisable Warrants will have to be exercised by the holder, failing which they will be deemed to be null and void:

		
	a)
	within ninety (90) days of the Office Termination, 

		
	b)
	at the latest immediately prior to the completion of the above mentioned Operation, it being specified that the Company will have to inform the holder of Warrants of the completion of any Operation of which he might not be aware at least fifteen (15) days in advance, or

		
	c)
	within six (6) months following the occurrence of the death or incapacity of the Warrants holder,

it being specified that, on the one hand, the Warrants which would not be exercisable at the date of occurrence of one of the events listed under paragraph (a) to (c) above will automatically lapse and that, on the other hand, the above mentioned delays do not result in an extension of the validity of the Warrants beyond the above ten-year (10) period.

2.2.    Method of Exercise 

The Warrants are exercisable by delivery of an exercise notice, in the form attached hereto under exhibit 2 (the "Exercise Notice"), comprising a share subscription form (bulletin de souscription) which shall state the Beneficiary’s election to exercise all or parts of the Warrants and the number of shares in respect of which the Warrants are being exercised (the "Exercised Shares"). The Exercise Notice shall be signed by the Beneficiary and shall be delivered in person or by certified mail to the Company or its designated representative or by facsimile message to be immediately confirmed by certified mail to the Company. The Exercise Notice shall be accompanied by the payment of the aggregate exercise price of all Exercised Shares. If the subscription price of the shares is paid by wire transfer, the subscription price of the shares will have to be paid on the Company’s bank account at the latest within 10 calendar days following the receipt by the Company of the Exercise Notice. The Warrants shall be deemed to be exercised upon receipt by the Company of such fully executed Exercise Notice accompanied by the proof of payment of such aggregate exercise price.

Upon exercise of the Warrants, the shares issued to the Beneficiary shall be assimilated with all other ordinary shares of the Company and shall be entitled to dividend for the fiscal year during which the Exercised Shares are subscribed and issued.

2.3.     Payment of the Exercised Shares

Payment of the aggregate exercise price of the Exercised Shares shall be made, at the election of the Beneficiary, by offset against receivables in accordance with applicable French law. 

Article 3 – Other Terms of the Warrants

In the event of a reduction in share capital of the Company due to losses by way of reduction of the number of outstanding shares of the Company, the right of the holder of the Warrants as regards the number of shares to be issued upon exercise of the Warrants shall be reduced accordingly, as if the Warrants holder had been a shareholder of the Company as from the date of issuance of the Warrants.

2

In the event of a reduction in share capital of the Company due to losses by way of reduction of the par value of the Company’s shares, the subscription price of the shares issued upon exercise of the Warrants shall not change, the issue premium being increased by the amount of the reduction of the par value.

In the event of a reduction in share capital of the Company not related to losses by way of reduction of the par value of the shares, the subscription price of the shares issued upon exercise of the Warrants shall be reduced accordingly.

In the event of a reduction in share capital of the Company not related to losses by way of reduction of the number of shares, the holder of the Warrants, if he exercises the Warrants, shall be entitled to request the repurchase of his shares under the same conditions as if he had been a shareholder of the Company as at the date of the repurchase by the Company of its own shares.

In case of rights issue (in which all shareholders are offered to participate prorata their respective equity stake), the Company will take either or several of the following decisions to preserve the rights of the holder of the Warrants, in accordance with the provisions of article L. 228-99 of the French commercial code:
1. either permit the holder of the Warrants to exercise it immediately to enable the Beneficiary to participate in the rights issue, which will not alter or limit the rights of the Beneficiary to exercise the Warrants under Section 2.1 of this Warrant Agreement; or
2. take any measures which will allow the Beneficiary, should he exercises the Warrants subsequently, to irrevocably subscribe at that time its prorata share of the new issue or obtain a free allotment, or receive cash or goods similar to those distributed in the rights issue, in the same quantities or proportions and under the same conditions as if the Beneficiary already exercised the Warrants and had thus been a shareholder of the Company at the time when those operations took place, or
3. adjust the conditions of subscription initially fixed in order to take account of the impact of the rights issue. In that case, such adjustment will be carried out by applying the method provided for in article R. 228-91 of French commercial code, it being specified that the value of the preferential subscription right as well as the value of the share before detachment of the subscription right shall be determined, if need be, by the board of directors on the basis of the subscription, exchange or sale price per share retained at the time of the last operation occurred on the Company's share capital (share capital increase, contribution in kind, sale of shares, etc.) during the six (6) month-period preceding the said meeting of the board of directors, or, if no such operation has been carried out during the said period, on the basis of any other financial parameter that appears relevant to the board of directors (and which will be confirmed by the Company's auditor).
The Company is authorized, without requesting the specific consent of the holder of the Warrants, to modify its corporate form and its corporate purpose.

It is reminded that, in compliance with the provisions of article L. 228-98 of the French commercial code, the Company cannot amend the rules regarding profit allocation, amortize the share capital and create and issue preferred shares entailing any such modification or amortization without requesting the specific consent of the holder of the Warrants.

Article 4 - Governing Law

This agreement is governed by the laws of the Republic of France. Any claim or dispute arising under this agreement shall be subject to the exclusive jurisdiction of the court competent for the place of the registered office of the Company.

Made in _____,
On [___], 20[___],
In two copies,

3

	
		
	[Name]
	CRITEO
Benoît Fouilland
Directeur général délégué

        
                        

4

EXHIBIT 1 

SUBSCRIPTION FORM OF THE WARRANTS

5

CRITEO

French société anonyme
Registered office : 32 rue Blanche, 75009 Paris
484 786 249 R.C.S. PARIS
___________________________

WARRANT SUBSCRIPTION FORM

Amount and terms of the issuance of the warrants

Issuance at a total price of USD [____] of [____] warrants (hereafter the “Warrants”), giving the right to subscribe for a maximum number of [____] ordinary shares, at a fixed price of EUR [___] each (issue premium included), to be fully paid up in cash or by way of offset against receivables and the subscription of which has been reserved to the subscriber.

The issuance has been decided by the board of directors of Criteo SA on [___], 20[___], pursuant to the authorization granted to it by the combined ordinary and extraordinary shareholders meeting of [_____].

The terms and conditions of the Warrants are described in the warrant agreement executed by the subscriber and Criteo on [___], 20[___].

The subscription period is opened until [___], 20[___] included.

--ooOoo—

The undersigned:

[Name], a [nationality] citizen, residing at [address],

acknowledging the terms and conditions of the Warrants,

hereby subscribes the Warrants and pays the amount of the subscription by way of offset against receivables held by the undersigned against the Company.

Made in _______________
On __________________, 20____
In two copies

__________________
[Name]

1

EXHIBIT 2

EXERCISE NOTICE OF THE WARRANTS

	
			
	

	 
	 

CRITEO

French société anonyme
Registered office : 32 rue Blanche, 75009 Paris
484 786 249 R.C.S. PARIS
___________________________

SHARE SUBSCRIPTION FORM

CRITEO
32, rue Blanche
75009 Paris
France

[Name], a [nationality] citizen, residing at [address],

holder of ___________________ Warrants, each giving right to subscribe for an ordinary share of Criteo (the “Company”) issued pursuant to the resolution of the board of directors of the Company held on [___], 20[___],

having examined the terms and conditions of the Warrants,

hereby 

exercises __________ Warrants

and

subscribes consequently for ________________ ordinary shares of the Company, for a subscription price per share of EUR ______________, share premium included, 

pays, for this subscription, the total amount of EUR _____________________ corresponding to the aggregate of the nominal value and the share premium of the above mentioned ordinary shares.

Made in  
On 
In two copies

__________________
[Name]3-1-17 Exhibit 101

		

			 

		

		
			Exhibit 10.1
		

		
			﻿
		

		
			FIRST AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT 
		

		
			﻿
		

		
			This FIRST AMENDMENT TO AMENDED AND RESTATED REVOLVING CREDIT AGREEMENT (this "Amendment") dated effective as of February 28, 2017, is entered into by and between LINDSAY CORPORATION, a Delaware corporation ("Borrower"), and WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association ("Bank").
		

		
			 
		

		
			Recitals
		

		
			﻿
		

		
			WHEREAS, Borrower and Bank are parties to that certain Amended and Restated Revolving Credit Agreement dated as of February 18, 2015 (the "Credit Agreement"), pursuant to which Bank agreed to lend to Borrower an aggregate principal sum of up to $50,000,000.00; and
		

		
			﻿
		

		
			WHEREAS, Borrower and Bank desire to amend the Credit Agreement to provide for the changes referred to herein.
		

		
			﻿
		

		
			NOW, THEREFORE, in consideration of the mutual covenants contained herein, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, Borrower and Bank agree to amend the Credit Agreement as follows:
		

		
			﻿
		

		
			1.Definitions.  Capitalized terms used herein but not otherwise defined shall have the meaning ascribed to them in the Credit Agreement (as defined above).
		

		
			﻿
		

		
			2.Definition of "Authorized Individual".  The definition of "Authorized Individual” is amended by replacing James C. Raabe with Brian L. Ketcham.
		

		
			﻿
		

		
			3.Definition of "Letter of Credit Sublimit".  The definition of "Letter of Credit Sublimit" is amended to mean Fifteen Million Dollars ($15,000,000.00).
		

		
			﻿
		

		
			4.Definition of "LIBOR Rate".  The definition of "LIBOR Rate" is amended to mean (i) for the purpose of calculating effective rates of interest for Loans making reference to LIBOR Periods, the rate of interest per annum determined by Bank based on the rate for United States dollar deposits for delivery on the first day of each LIBOR Period for a period approximately equal to such LIBOR Period as published by the ICE Benchmark Administration Limited, a United Kingdom company, at approximately 11:00 a.m., London time, two (2) London Business Days prior to the first day of such LIBOR Period (or if not so published, then as determined by Bank from another recognized source or interbank quotation), or (ii) for the purpose of calculating effective rates of interest for Loans making reference to the Daily One Month LIBOR Rate, the rate of interest per annum determined by Bank based on the rate for United States dollar deposits for delivery of funds for one (1) month as published by the ICE Benchmark Administration Limited, a United Kingdom company,  at approximately 11:00 a.m., London time, or, for any day not a London Business Day, the immediately preceding London Business Day (or if not so published, then as determined by Bank from another recognized source or interbank quotation); provided, however, that if the LIBOR Rate determined as provided above would be less than zero percent (0.0%), then the LIBOR Rate shall be deemed to be zero percent (0.0%).
		

		
			﻿
		

		
			5.LIBOR Rate Margin Grid.  The "grid" in the definition of "LIBOR Rate Margin" is hereby amended and restated in its entirety as follows:
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		
			﻿
		

		

		

		 

		

			1

		

		

			 

		

 

		

			

		

			 

		

		

			 

		

		

		﻿
		

			
					
						﻿

					
					
						 

				
	
					
						Leverage Ratio*

					
					
						LIBOR Rate Margin

				
	
					
						≤ 0.99x

					
					
						0.90%

				
	
					
						1.00x ≤ 1.74x

					
					
						1.20%

				
	
					
						1.75x ≤ 1.99x

					
					
						1.40%

				
	
					
						2.00x ≤ 2.24x

					
					
						1.65%

				
	
					
						≥ 2.25x

					
					
						2.00%

				

		
			﻿
		

		
			*Calculated on a four-fiscal quarter rolling basis as provided in the definition of "Leverage Ratio."                                             
		

		
			﻿
		

		
			6.Definition of Termination Date.  The definition of "Termination Date" is amended to mean February 28, 2020.
		

		
			﻿
		

		
			7.Amendment to Section 2.1(a).  The provision in Section 2.1(a) of the Credit Agreement which reads "Borrower's obligation to repay Loans shall be evidenced by a promissory note dated as of the date hereof ("Line of Credit Note"), all terms of which are incorporated herein by this reference" shall be amended and replaced as follows:  "Any Loans made hereunder shall be evidenced by that certain Amended and Restated Line of Credit Note dated on or about February 28, 2017, as may be amended or restated from time to time ("Line of Credit Note"), all terms of which are incorporated herein by this reference."
		

		
			﻿
		

		
			8.Amendment to Section 5.9(b).  Section 5.9 of the Credit Agreement is hereby amended and restated in its entirety to read:  "(b) Leverage Ratio not greater than 2.75 to 1.0 as of the end of such fiscal quarter of Borrower then ended."
		

		
			﻿
		

		
			9.Internal References.  References in the Credit Agreement to the "Line of Credit Note" shall refer to Amended and Restated Line of Credit Note dated on or about the date hereof, as may be amended and restated from time to time.  
		

		
			﻿
		

		
			10.Effectiveness.  This Amendment shall become effective when and only when the Bank shall have received (a) counterparts of this Amendment duly executed by the Borrower; (b) the Amended Note dated effective as of the date hereof, duly executed by the Borrower; and (c) such other documents, actions or assurances as Bank may reasonably request.
		

		
			﻿
		

		
			11.Representations and Warranties of Borrower.  Borrower represents and warrants as follows:
		

		
			﻿
		

		
			(a)The execution, delivery and performance by Borrower of this Amendment and the Credit Agreement, as amended hereby, (i) are within Borrower's powers, (ii) have been duly authorized by all necessary action, (iii) do not result in, or require, the creation of any lien, security interest or other charge or encumbrance upon or with respect to the Collateral, and (iv) do not contravene (A) Borrower's organizational documents, or (B) any law or contractual restriction binding on or affecting Borrower.
		

		
			﻿
		

		
			(b)This Amendment and the Credit Agreement as amended hereby constitute legal, valid and binding obligations of Borrower and are enforceable against Borrower in accordance with their respective terms.
		

		
			﻿
		

		
			(c)There is no pending or threatened action or proceeding affecting Borrower before any court, governmental agency or arbitrator, which may materially adversely affect the financial condition or operations of Borrower.
		

		
			﻿
		

		
			(d)No breach of any representation or warranty made by Borrower pursuant to Article 5 of the Credit Agreement or any covenant made by Borrower pursuant to Article 6 of the Credit Agreement has occurred and is continuing.
		

		
			﻿
		

		
			12.Reference to and Effect on the Credit Agreement.  Upon the effectiveness of Section 10 of this Amendment, on and after the date hereof, each reference in the Credit Agreement to "this Agreement", "hereunder" "hereof", "herein" or words of like import shall mean and be a reference to the Credit Agreement as amended by this Amendment.
		

		
			﻿
		

		

		

		 

		

			2

		

 

		

			

		

			 

		

		

			 

		

		

		(a)Except as specifically amended above, the Credit Agreement shall remain in full force and effect and is hereby ratified and confirmed.
		

		
			﻿
		

		
			(b)The execution, delivery and effectiveness of this Amendment shall not operate as a waiver of any right, power or remedy of the Bank under the Credit Agreement, nor constitute a waiver of any provision of the Credit Agreement.
		

		
			﻿
		

		
			13.Execution in Counterparts.  This Amendment may be executed in one or more counterparts, not all of which need to be signed by the same parties, but all of which taken together shall constitute one and the same instrument.  The parties may execute this Amendment and exchange counterparts by means of facsimile transmission or electronic mail, and the parties agree that the receipt of such counterparts shall be binding on the parties and shall be construed as originals.
		

		
			﻿
		

		
			14.Governing Law.  This Amendment shall be governed by, and construed in accordance with, the laws of the State of Nebraska, without regard to its principles of conflict of laws.
		

		
			﻿
		

		
			﻿
		

		
			THE REMAINDER OF THIS PAGE IS INTENTIONALLY BLANK
		

		

		

		 

		

			3

		

 

		

			

		

			 

		

		

			 

		

		

		IN WITNESS WHEREOF, the parties hereto, intending to be legally bound hereby, have caused this Amendment to be executed as of the day and year first written above.
		

		
			﻿
		

		
			BANK:
		

		
			﻿
		

		
			WELLS FARGO BANK, NATIONAL ASSOCIATION, a national banking association
		

		
			﻿
		

		
			﻿
		

		
			By: /s/ Michael H. Wheeler
		

		
			Michael H. Wheeler, Vice President
		

		
			﻿
		

		
			﻿
		

		
			BORROWER:
		

		
			﻿
		

		
			LINDSAY CORPORATION, a Delaware corporation
		

		
			﻿
		

		
			﻿
		

		
			By: /s/ Richard W. Parod
		

		
			Richard W. Parod, Chief Executive Officer
		

		
			﻿
		

		 

		

			4

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00267-of-00352.parquet"}]]